PH18532A - Novel carbostyril derivatives and pharmaceutical compositions containing the same - Google Patents

Novel carbostyril derivatives and pharmaceutical compositions containing the same

Info

Publication number
PH18532A
PH18532A PH24106A PH24106A PH18532A PH 18532 A PH18532 A PH 18532A PH 24106 A PH24106 A PH 24106A PH 24106 A PH24106 A PH 24106A PH 18532 A PH18532 A PH 18532A
Authority
PH
Philippines
Prior art keywords
same
pharmaceutical compositions
compositions containing
carbostyril derivatives
novel carbostyril
Prior art date
Application number
PH24106A
Other languages
English (en)
Inventor
Takao Nishi
Tatsuyoshi Tanaka
Kazuyuki Nakagawa
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of PH18532A publication Critical patent/PH18532A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
PH24106A 1980-02-29 1980-06-04 Novel carbostyril derivatives and pharmaceutical compositions containing the same PH18532A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2565880A JPS56122356A (en) 1980-02-29 1980-02-29 Carbostyril derivative

Publications (1)

Publication Number Publication Date
PH18532A true PH18532A (en) 1985-08-09

Family

ID=12171902

Family Applications (1)

Application Number Title Priority Date Filing Date
PH24106A PH18532A (en) 1980-02-29 1980-06-04 Novel carbostyril derivatives and pharmaceutical compositions containing the same

Country Status (24)

Country Link
US (1) US4435404A (ja)
JP (1) JPS56122356A (ja)
KR (2) KR860002099B1 (ja)
AT (1) AT381493B (ja)
AU (1) AU532319B2 (ja)
BE (1) BE883713A (ja)
CA (1) CA1159068A (ja)
CH (1) CH647765A5 (ja)
DE (1) DE3049959T1 (ja)
DK (1) DK151956C (ja)
ES (1) ES492230A0 (ja)
FI (1) FI76321C (ja)
FR (1) FR2477149A1 (ja)
GB (1) GB2070588B (ja)
IT (1) IT1129812B (ja)
MX (1) MX6752E (ja)
NL (1) NL185146C (ja)
NO (1) NO160512C (ja)
PH (1) PH18532A (ja)
PT (1) PT71359B (ja)
SE (1) SE461147B (ja)
SU (2) SU1169535A3 (ja)
WO (1) WO1981002421A1 (ja)
ZA (1) ZA803322B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578381A (en) * 1982-07-05 1986-03-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
DE3434271A1 (de) * 1984-09-19 1986-03-20 Beiersdorf Ag, 2000 Hamburg Substituierte 3,4-dihydro-chinolin-2(1h)-one verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
JP2753622B2 (ja) 1988-05-02 1998-05-20 大塚製薬株式会社 カルボスチリル誘導体
US5227381A (en) * 1988-05-02 1993-07-13 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivative
EP0569592A4 (en) * 1991-08-23 1994-12-07 Otsuka Pharma Co Ltd CARBOSTYRILE DERIVATIVE AND PLATELET ANTIAGGREGATOR.
JP2686887B2 (ja) * 1992-08-11 1997-12-08 キッセイ薬品工業株式会社 ピペリジノ−３，４−ジヒドロカルボスチリル誘導体
US7208497B2 (en) 2001-07-02 2007-04-24 Novo Nordisk A/S Substituted piperazines and diazepanes
TWI481601B (zh) * 2009-08-21 2015-04-21 Otsuka Pharma Co Ltd 含氮化合物及藥學組成物
IN2012DN00986A (ja) 2009-08-21 2015-04-10 Otsuka Pharma Co Ltd

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1021522A (en) * 1963-05-10 1966-03-02 Ici Ltd 2-quinolone derivatives
DE1527937A1 (de) * 1966-12-10 1969-11-13 Blanc & Co Verfahren zur Herstellung eines sich konisch verjuengenden,einen nach aussen abgewinkelten flachen Rand aufweisenden Hohlteils sowie Einrichtung zur Durchfuehrung des Verfahrens
JPS48103590A (ja) * 1972-04-13 1973-12-25
JPS5082218A (ja) * 1973-11-10 1975-07-03
JPS5310988B2 (ja) * 1974-04-25 1978-04-18
JPS5318030B2 (ja) * 1974-05-20 1978-06-13
FI59246C (fi) 1974-06-24 1981-07-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av benscykloamidderivat anvaendbara vid trombos- och emboliterapin
US4313947A (en) 1974-06-24 1982-02-02 Otsuka Pharmaceutical Co., Ltd. Platelet aggregation inhibiting 2-oxyindoles, their compositions and method of use
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
JPS5273879A (en) * 1975-12-18 1977-06-21 Otsuka Pharmaceut Co Ltd Synthesis of ester derivatives
JPS545981A (en) * 1977-06-10 1979-01-17 Otsuka Pharmaceut Co Ltd Carbostyryl derivatives
NZ187452A (en) * 1977-06-10 1980-05-27 Otsuka Pharma Co Ltd N- substituted-aminocarbonylpropoxy-carbostyrils and their preparation

Also Published As

Publication number Publication date
AU5985980A (en) 1981-09-11
GB2070588A (en) 1981-09-09
DE3049959C2 (ja) 1993-07-08
DK151956B (da) 1988-01-18
FR2477149B1 (ja) 1983-06-24
IT1129812B (it) 1986-06-11
JPS6334845B2 (ja) 1988-07-12
PT71359B (en) 1981-10-21
ZA803322B (en) 1982-01-27
KR860002099B1 (ko) 1986-11-25
KR860002100B1 (ko) 1986-11-25
DE3049959T1 (de) 1982-07-29
CA1159068A (en) 1983-12-20
NO160512B (no) 1989-01-16
US4435404A (en) 1984-03-06
SE8102690L (sv) 1981-08-30
DK151956C (da) 1988-08-15
CH647765A5 (de) 1985-02-15
DK250381A (da) 1981-09-03
WO1981002421A1 (en) 1981-09-03
KR840004681A (ko) 1984-10-22
NL185146C (nl) 1990-02-01
GB2070588B (en) 1983-10-19
SE461147B (sv) 1990-01-15
ATA909480A (de) 1986-03-15
IT8067888A0 (it) 1980-06-06
NO160512C (no) 1989-04-26
MX6752E (es) 1986-06-25
SU1395140A3 (ru) 1988-05-07
JPS56122356A (en) 1981-09-25
NO813477L (no) 1981-10-15
NL185146B (nl) 1989-09-01
BE883713A (fr) 1980-12-09
FI801843A (fi) 1981-08-30
SU1169535A3 (ru) 1985-07-23
FI76321C (fi) 1988-10-10
ES8105290A1 (es) 1981-05-16
ES492230A0 (es) 1981-05-16
FR2477149A1 (fr) 1981-09-04
NL8020199A (nl) 1981-12-01
AU532319B2 (en) 1983-09-22
PT71359A (en) 1980-07-01
FI76321B (fi) 1988-06-30
AT381493B (de) 1986-10-27
KR830002713A (ko) 1983-05-30

Similar Documents

Publication Publication Date Title
PH17194A (en) Novel carbostyril derivatives,and pharmaceutical composition containing the same
PH17460A (en) Hydantoin derivatives and pharmaceutical compositions containing the same
PH24267A (en) Androstane carbothioates and pharmaceutical compositions containing the same
IL73877A (en) Quinolone derivatives and pharmaceutical compositions containing them
IL72566A (en) Androst-5-en-17-one and 5alpha-androstan-17-one derivatives and pharmaceutical compositions containing the same
DE3168067D1 (en) 2-guanidino-4-heteroarylthiazoles and pharmaceutical compositions containing them
IL63423A0 (en) 9-amino-1-hydroxyoctahydrobenzo(c)quinoline derivatives and pharmaceutical compositions containing them
GB2088373B (en) Dibenzazepine derivatives and pharmaceutical compositions containing them
IL64054A0 (en) Imidazolylpyridines and pharmaceutical compositions containing them
PH18532A (en) Novel carbostyril derivatives and pharmaceutical compositions containing the same
IL60376A0 (en) 3-methyleneazetidine derivatives and pharmaceutical compositions containing them
IL64544A (en) Quinolone derivatives,their preparation and pharmaceutical compositions containing them
NZ198414A (en) Quinolone derivatives and pharmaceutical compositions
IL70189A (en) 2-piperazinyl-quinazoline derivatives,their proeuction and pharmaceutical compositions containing them
IL59177A0 (en) Spiro-quinolylhydantoins and pharmaceutical compositions containing them
NZ205732A (en) Thiatriazine derivatives and pharmaceutical compositions
PH16754A (en) Novel acylamino-benzazole derivatives,and pharmaceutical composition containing same
NZ203649A (en) 2-beta-d-ribofuranosylselenazole-4-carboxamide derivatives and pharmaceutical compositions
PH15118A (en) Octahydro-2h-pyrrolo(3-4-g)quinolines pharmaceutical composition containing same
JPS56139481A (en) Quinoline derivative and medicinal composition containing same
IL60695A0 (en) Hexahydro-trans-pyridoindole derivatives and pharmaceutical compositions containing them
IL61038A (en) 15-sulfonamidoprostaglandin derivatives and pharmaceutical compositions containing them
ZA814056B (en) Pharmaceutical bicyclo-octatriene compounds and compositions
NZ197416A (en) Penicillin derivatives and pharmaceutical compositions
IL62146A (en) Guanylamidines and pharmaceutical compositions containing them